Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-13 5:20 pm Purchase |
2023-12-08 | 13G | Finch Therapeutics Group, Inc. FNCH |
Ugwumba Chidozie | 160,366 9.990% |
43,699 (+37.46%) |
Filing History |
| 2022-02-14 3:59 pm Sale |
2021-12-31 | 13G | Finch Therapeutics Group, Inc. FNCH |
Walton Thomas Layton | 0 0.000% |
-116,239 (Position Closed) |
Filing History |
| 2022-02-14 3:46 pm Purchase |
2021-12-31 | 13G | Finch Therapeutics Group, Inc. FNCH |
Ugwumba Chidozie | 116,667 7.370% |
116,667 (New Position) |
Filing History |
| 2021-04-01 5:22 pm Purchase |
2021-03-23 | 13D | Finch Therapeutics Group, Inc. FNCH |
Crestovo Investor LLC | 421,381 26.800% |
421,381 (New Position) |
Filing History |
| 2021-03-29 4:41 pm Purchase |
2021-03-19 | 13D | Finch Therapeutics Group, Inc. FNCH |
Haft Nicholas | 133,102 8.500% |
133,102 (New Position) |
Filing History |
| 2021-03-26 4:47 pm Purchase |
2021-03-23 | 13G | Finch Therapeutics Group, Inc. FNCH |
Walton Thomas Layton | 116,239 7.400% |
116,239 (New Position) |
Filing History |